Nossent H C, Swaak T J
Department of Rheumatology, Dr. Daniel den Hoed Clinic, Rotterdam, The Netherlands.
J Rheumatol. 1990 Jun;17(6):771-6.
The influence of systemic lupus erythematosus (SLE) on pregnancy and vice versa was examined during 39 pregnancies in 19 patients, and outcome was compared with 24 pregnancies in 18 other patients before SLE was established. No difference in fetal loss or premature birth rate was found, although more babies were born with low birth weight after SLE was diagnosed; there was a preponderance of female babies in both groups. Pregnancy during SLE was accompanied by disease exacerbations in up to 74% of all patients. These exacerbations concerned mostly musculoskeletal (41%) and hematological abnormalities (36%), while organ involvement occurred in 13% of all exacerbations. No differences in pregnancy outcome during SLE were found between patients with active or quiescent disease, as established by the lupus activity criteria count (LACC). The presence of antibodies to SSA in the mother was associated with the occurrence of congenital heart block; no association was found between antiphospholipid antibodies and fetal loss.
研究了19例患者的39次妊娠中系统性红斑狼疮(SLE)对妊娠的影响以及妊娠对SLE的影响,并将结果与18例其他患者在SLE确诊前的24次妊娠进行了比较。尽管SLE确诊后出生低体重儿的情况更多,但未发现胎儿丢失率或早产率存在差异;两组中女婴均占多数。SLE患者妊娠期间,高达74%的患者病情会加重。这些加重情况大多涉及肌肉骨骼(41%)和血液学异常(36%),而所有病情加重情况中有13%出现器官受累。根据狼疮活动标准计数(LACC)确定,疾病处于活动期或静止期的患者在SLE妊娠期间的妊娠结局无差异。母亲体内抗SSA抗体的存在与先天性心脏传导阻滞的发生有关;未发现抗磷脂抗体与胎儿丢失之间存在关联。